Multi-center trial will assess safety and efficacy of ASI-02 contrast agent in cardiac bubble studies. ST. PAUL, Minn., April 08, 2025--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Agitated Solutions, Incorporated (ASI) announced today that it has been issued a Medical Device Establishment License (MDEL) from Health Canada for its innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results